Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03510117 · ClinicalTrials.gov registry record · NA

Creating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
8,152
Enrollment target

NCT03510117 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 8,152 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03510117, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
8,152 participants
Enrollment target

Study Summary

While MBI trials have reached a greater level of rigor (e.g., random assignment, matching on time, attention, teacher characteristics, non-specific factors) a significant gap still remains in mindfulness research: the lack of a comprehensive and standardized self-report measurement system. A precise, carefully constructed set of assessment tools based on a common measurement system are needed; where scores can be psychometrically linked to current "legacy" measures to better understand the existing body of mindfulness research. In this study, Creating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation (COMMENCE), the investigators will use Patient Reported Outcomes Measurement Information System (PROMIS) methodologies to construct improved self-report mindfulness-related measures. They will also use PROMIS-based PROsetta Stone linking methods to equate scores and create cross-walks between new mindfulness measures and existing ones.

Interventions

  • BEHAVIORAL Mindfulness

Trial Details

FieldValue
Enrollment Target 8,152 participants
Start Date 2017-07-01
Est. Completion 2022-07-26
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT03510117

The ClinicalTrials.gov registry entry for NCT03510117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8,152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mindfulness is the first listed.

NCT03510117 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03510117 about?

NCT03510117 is a clinical study titled "Creating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation". While MBI trials have reached a greater level of rigor (e.g., random assignment, matching on time, attention, teacher characteristics, non-specific factors) a significant gap still remains in mindfulness research: the lack of a comprehensive and standardized self-report measurement system. A precise...

What is the current status of trial NCT03510117?

This trial is currently completed. It is a NA study. The enrollment target is 8,152 participants. The study started on 2017-07-01. Estimated completion is 2022-07-26.

What interventions are being tested in trial NCT03510117?

The interventions under investigation include: Mindfulness (BEHAVIORAL).

Who is sponsoring clinical trial NCT03510117?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.